---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-057134"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:23:25.664234+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Astrana Health Q1 revenue up 56% to $965M; adjusted EBITDA up 82% to $66.3M

## Summary
- Total revenue $965.1M, up 56% YoY; Care Partners revenue $909.7M, up 51%.
- Net income attributable to Astrana $14.4M, up 116%; diluted EPS $0.29, up 107%.
- Adjusted EBITDA $66.3M, up 82%; adjusted diluted EPS $0.74, up 76%.
- Net cash from operations $68.1M (up 309%); free cash flow $64.1M (up 372%).

## SEC filing metadata
- accession: 0001104659-26-057134
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465926057134/0001104659-26-057134-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465926057134/tm2613886d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-057134
- JSON: https://secwatch.observer/filing/0001104659-26-057134.json
- Plain text: https://secwatch.observer/filing/0001104659-26-057134.txt

## Source-grounded claims
- claim_id: 6b88b6553474132cd69ed162250bd2f98791435d
  claim: Astrana Health, Inc. reported first quarter ended March 31, 2026 results: revenue $965.1 million, net income $14.4 million, EPS $0.29.
  evidence_excerpt: Financial Highlights for First Quarter Ended March 31, 2026: All comparisons are to the three months ended March 31, 2025 unless otherwise stated. · Total revenue of $965.1 million, up 56% from $620.4 million · Care Partners revenue of $909.7 million, up 51% from $601.0 million · Net income attributable to Astrana of $14.4 million, up 116% from $6.7 million · Earnings per share (“EPS”) - diluted of $0.29, up 107% from $0.14
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465926057134/0001104659-26-057134-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.